publication venue for
- A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals.. 240:114570-114570. 2022
- A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals.. 240:114596-114596. 2022
- 6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis.. 226:113843-113843. 2021
- Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition.. 152:31-52. 2018
- Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.. 144:859-873. 2018
- Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.. 141:306-321. 2017
- Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.. 134:392-405. 2017
- Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.. 108:274-286. 2016
- Discovery of InhA inhibitors with anti-mycobacterial activity through a matched molecular pair approach.. 94:378-385. 2015
- Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents.. 87:868-880. 2014
- Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives.. 45:572-580. 2010
- Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.. 43:1376-1389. 2008
- DESIGN OF NOVEL RXR SELECTIVE RETINOIDS 1995